bbr 3464
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2000 (NCT00014547)
Timeline
2000s
- Jan 1, 2000
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- bbr 3464
- bbr 3464
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00024362 | Phase 2 | May 1, 2001 | Oklahoma Oncology, Theradex |
| NCT00014547 | Phase 2 | Nov 1, 2000 | Theradex, University of North Carolina at Chapel Hill |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Theradex | For profit | 2 | 2 | 1 | 2000 |
| Oklahoma Oncology | Academic/Hospital | 1 | 0 | 1 | 2001 |
| University of North Carolina at Chapel Hill | Academic/Hospital | 1 | 0 | 1 | 2000 |
3 organizations
Page 1 / 1